Prevention of mother-to-child transmission of HIV in Africa: Successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia

AIDS

Volumn 17, Issue 9, 2003, Pages 1377-1382

  Stringer, Elizabeth M ^a,b,c,d   Sinkala, Moses ^a,b,c   Stringer, Jeffrey S A ^a,b,c   Mzyece, Elizabeth ^c   Makuka, Ida ^c   Goldenberg, Robert L ^a,c   Kwape, Pascal ^c   Chilufya, Martha ^c   Vermund, Sten H ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ZAMBIA   (Zambia)

^c MINISTRY OF HEALTH   (Zambia)

^d CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

Author keywords

AIDS; Child; Cost effectiveness; HIV; Infant; Mother to child; Nevirapine; Perinatal; Pregnancy; Southern Africa; Sub Saharan Africa; Transmission; Women; Zambia

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AFRICA; ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS TRANSMISSION; ZAMBIA;

ANTIVIRAL AGENTS; COST-BENEFIT ANALYSIS; COUNSELING; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; DRUG COSTS; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MALE; NEVIRAPINE; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; URBAN HEALTH; ZAMBIA;

EID: 0038675429     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200306130-00012     Document Type: Article

References (15)

1. Fylkesnes K, Musonda R, Kasumba K, Mubanga, Musonda R, Sichone M. The HIV epidemic in Zambia: socio-demographic prevalence patterns and indications of trends among childbearing women. AIDS 1997, 11:339-345.
2. Stringer J, Sinkala M, Stout J, Acosta EP, Chapman V, Kumwenda, et al. Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. J AIDS 2003, in press.
3. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000, 283:1175-1182.
4. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354:795-802.
5. Boerhringer-Ingelheim. VIRAMUNE® Donation Programme for the Prevention of Mother-to-Child Transmission of HIV-1. http://www.viramune-donation-program.org, Accessed May 31, 2002.
6. Fowler M, Mwatha A, Guay L, Musoke P, Mmiro F, Fleming T, et al. Effect of nevirapine (NVP) for perinatal HIV prevention appears greatest among women with most advanced disease: subgroup analyses of HIVNET 012. Ninth Conference on Retro-viruses and Opportunistic Infections. Seattle, February 2002 [abstract 120].
7. Buyse D, Nuwaha F, Karlin T, Wilfert C. Prevention of mother to child HIV transmission: from research to action. XIV International Conference on AIDS. Barcelona, July 2002 [abstract TuPeF5413].
8. Kalyesubula I, Mubiru M, Bakaki P, Kintu, Owor M, Kibuu E, et al. Factors affecting revealing of HIV status to the spouses by infected women attending mother-child and pediatric AIDS/HIV clinics at old Mulago. XIV International Conference on AIDS. Barcelona, July 2002 [abstract ThPeD7640].
9. Sweat M, O'Reilly K, Schmid G, Denison J, de Zoysa I. The cost-effectiness of nevirapine use in antenatal clinics in Africa is significantly impaired by lack of client uptake. XIV International Conference on AIDS. Barcelona, July 2002 [abstract TuPeC48621].
10. Shutes E, Vwalika C, Kasonde P, Sinkala M, Kankasa C, Allen S, et al. Involvement of men in programs to prevent mother to child transmission of HIV. XIV International Conference on AIDS. Barcelona, July 2002 [abstract MoOrF1032].
11. Marseille E, Kahn J, Mmiro F, Guay L, Musoke P, Fowler M, et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet 1999, 354:803-809.
12. Stringer JSA, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett A. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J AIDS 2000, 24:369-377.
13. Stringer E, Stringer J, Cliver S, Goldenberg RL, Goepfert AR. Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates. Obstet Gynecol 2001, 98:1104-1108.
14. Stringer J, Sinkala M, Rouse D, Goldenberg R, Vermund SH. Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Pub Health 2002, 92:365-366.
15. Rosenfield A, El-Sadr W, Rabkin M, Hammer S, Abrams E, Kuhn L, et al. The MTCT Plus Program: a major initiative to provide care and treatment to HIV-infected women and their children. XIV International Conference on AIDS. Barcelona, July 2002 [abstract MoPeB3244].